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Abstract Cardiorespiratory fitness (CRF), an index of cardiac and respiratory functioning, is strongly 
associated with a reduced risk of adverse health outcomes. We aimed to assess the prospective association 
of CRF with the risk of respiratory diseases (defined as chronic obstructive pulmonary disease, 
pneumonia, or asthma). Cardiorespiratory fitness, as measured by maximal oxygen uptake, was assessed 
in 1,974 middle-aged men. During a median follow-up of 25.7 years, 382 hospital diagnosed respiratory 
diseases were recorded. Cardiorespiratory fitness was linearly associated with risk of respiratory diseases. 
In analysis adjusted for several established and potential risk factors, the hazard ratio (HR) (95% CI) for 
respiratory diseases was 0.63 (0.45-0.88), when comparing extreme quartiles of CRF levels. The 
corresponding multivariate adjusted HR (95% CI) for pneumonia was 0.67 (0.48-0.95). Our findings 
indicate a graded inverse and independent association between CRF and the future risk of respiratory 
diseases in a general male Caucasian population.  
 
Keywords cardiorespiratory fitness; maximal oxygen uptake; respiratory disease; pneumonia; chronic 
obstructive pulmonary disease; asthma 
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Abbreviations 
CI Confidence interval 
COPD Chronic obstructive pulmonary disease 
CRF Cardiorespiratory fitness 
HR Hazard ratio 
KIHD Kuopio Ischemic Heart Disease 
SD Standard deviation 
VO2max Maximal oxygen uptake  
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Introduction 
Respiratory diseases such as chronic obstructive pulmonary disease (COPD), pneumonia, and asthma are 
debilitating diseases of the lungs and airways. Chronic obstructive pulmonary disease is an incurable 
progressive obstructive lung disease which is characterized by chronic poor airflow.[1] In 2012, COPD 
was the third leading cause of death globally.[2] Pneumonia affects about 450 million people worldwide 
and causes approximately 4 million deaths annually.[3] Asthma is a common inflammatory disease of the 
airways of the lungs and causes about 250,000 to 345,000 deaths annually.[4] Apart from the high 
mortality rates associated with these respiratory diseases, they are also disabling conditions and account 
for increased healthcare costs and recurrent hospitalizations. For example, COPD represents three percent 
of the healthcare spending in Europe.[5] These most common respiratory diseases are caused by an 
interaction of environmental and genetic risk factors. Major environmental risk factors implicated in their 
etiology include smoking, exposure to pollution and environmental chemicals with coexisting chronic 
disease such as diabetes.[5-7] Most cases of these respiratory diseases are potentially preventable through 
reduction in exposure to underlying risk factors. Physical activity is well established to have important 
health benefits including the prevention of adverse vascular and non-vascular outcomes[8,9] and has been 
shown to improve prognosis of patients with respiratory diseases.[10] Cardiorespiratory fitness (CRF), as 
measured by maximal oxygen uptake (VO2max), is considered the gold standard for assessing aerobic 
capacity, is an indicator of cardiovascular and pulmonary function, and an index of the level of physical 
activity.[11] Cardiorespiratory fitness is an established independent risk marker for vascular and non-
vascular outcomes.[12] Taken the evidence together, we hypothesized that CRF may be linked to the 
development of respiratory diseases. We therefore aimed to assess the prospective association of CRF 
with risk of respiratory diseases, using a population-based cohort of 1,974 middle-aged Finnish men, who 
were apparently free from any respiratory diseases at baseline.  
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Methods 
The current analyses were based on the Finnish Kuopio Ischemic Heart Disease (KIHD) risk factor study 
which comprised a representative sample of middle-aged men aged 42-61 years recruited from Kuopio in 
eastern Finland. The Research Ethics Committee of the University of Eastern Finland approved all study 
procedures which was conducted according to the Declaration of Helsinki. Each participant provided 
written informed consent. Details of recruitment methods and measurements of risk markers have been 
described previously.[13] We assessed CRF using directly measured VO2max, which is considered the gold 
standard expression of CRF. Repeat measurements were also performed several years apart in a random 
subset of participants. A detailed description of the measurement of VO2max has been reported 
elsewhere.[14] Briefly, a maximal symptom-limited exercise tolerance test was performed between 
08:00-10:00 hours using an electrically braked cycle ergometer. The standardized testing protocol 
comprised of an increase in the workload of 20 W/min with the direct analyses of respiratory gases by 
breath-by-breath method using a MGC respiratory gas exchange analyzer (Medical Graphics, St. Paul, 
Minnesota). The VO2max was defined as the highest value for or the plateau of oxygen uptake. Reference 
values for VO2max were based on established reference values derived from a Norwegian cohort.[15] All 
incident respiratory diseases diseases (defined as COPD, pneumonia, or asthma) that occurred from study 
entry to 2014 were included. Outcomes were collected by linkage to the National Hospital Discharge 
Register. The diagnoses of outcomes were made by qualified physicians based on the International 
Classification of Disease codes. For the current analysis, all men with respiratory diseases (chronic 
bronchitis, asthma, or tuberculosis) at study entry (n=344) were excluded. Hazard ratios (HRs) with 95% 
confidence intervals (CIs) were estimated using Cox proportional hazard models. All statistical analyses 
were conducted using Stata version 14 (Stata Corp, College Station, Texas). 
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Results 
The overall mean [standard deviation (SD)] age and CRF of study participants at baseline were 53 (5) 
years and 30.7 (8.0) ml/kg/min respectively. A total of 382 hospital diagnosed respiratory diseases were 
recorded (annual rate 8.86/1000 person-years at risk; 95% CI 8.01 to 9.79) during a median (interquartile 
range) follow-up of 25.7 (16.9-27.8) years. The overall age-adjusted regression dilution ratio of CRF was 
0.57 (95% CI: 0.51 to 0.63), which implies that the association of CRF with risk of respiratory disease 
outcomes using baseline measurements of CRF only, could under-estimate the risk by [(1/0.57)-1]*100 = 
75%. Cardiorespiratory fitness was linearly and inversely associated with risk of respiratory disease 
outcomes after adjustment for several established risk factors (age, smoking status, histories of diabetes 
and coronary heart disease, years of education, and alcohol consumption) (Figure). In age-adjusted 
analysis, the HR for respiratory disease per 1 SD increase in CRF was 0.66 (95% CI: 0.59 to 0.74), which 
was minimally attenuated on further adjustment for established risk factors 0.75 (95% CI: 0.66 to 0.85). 
The association persisted on additional adjustment for total energy intake, socioeconomic status, physical 
activity, and C-reactive protein 0.81 (95% CI: 0.71 to 0.92). Comparing the extreme quartiles of CRF 
levels, the corresponding adjusted HRs were 0.40 (95% CI: 0.29 to 0.55), 0.53 (95% CI: 0.38 to 0.74), 
and 0.63 (95% CI: 0.45 to 0.88) respectively. Correction for within-person variability in CRF levels 
strengthened the respective associations (Table). Given that pneumonia is a transient condition, a separate 
analysis of the association between CRF and pneumonia was conducted. Cardiorespiratory fitness was 
inversely associated with risk of pneumonia in a graded dose-response fashion. In a comparison of 
extreme quartiles of CRF levels, the HR for pneumonia was 0.58 (95% CI: 0.41 to 0.80) in analysis 
adjusted for several established risk factors for pneumonia. The association remained consistent on further 
adjustment for total energy intake, socioeconomic status, physical activity, and C-reactive protein 0.67 
(95% CI: 0.48 to 0.95). 
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Discussion 
In this first prospective evaluation of the association between CRF and risk of respiratory outcomes in 
middle-aged Caucasian men who had no apparent pre-existing respiratory diseases at baseline, the 
findings showed an inverse and dose-response relationship between CRF and future risk of respiratory 
diseases (defined as COPD, pneumonia, or asthma). The association was independent of several risk 
factors for these outcomes. A subsidiary analysis showed CRF to be inversely associated with risk of 
pneumonia in a graded dose-response fashion. Though these diseases are as a result of an interplay of 
environmental and genetic factors, inflammatory processes mainly underlie their pathogenesis.[5,16] The 
protective association demonstrated between CRF and respiratory diseases may also be exerted via the 
anti-inflammatory effects of regular physical activity.[17] Our current findings suggest that regular 
physical activity, which promotes good CRF levels, may be able to reduce the risk of respiratory diseases 
in the general population. Indeed, it has been consistently shown that physical activity protects against the 
development of chronic disease outcomes.[8,9] However, further research is needed to replicate these 
findings, elucidate the mechanistic pathways involved, and whether information on CRF levels can be 
used to identify individuals at high risk of respiratory diseases in clinical practise. 
Our analysis employed a large-scale population-based prospective cohort design with inclusion of men 
who were representative of the general population and were free of any diagnosed respiratory diseases at 
baseline; follow-up was long and complete for all participants; and the analysis was comprehensive which 
included adjustment for several potential confounders, assessment of the dose-response relationship 
between the exposure and outcome,  as well as correction for within-person variability in CRF levels. The 
results should be interpreted with caution given the limitations of: (i) the inability to generalise the 
findings to women and other populations; (ii) the possibility of residual confounding given the 
observational design, and (iii) the broad classification of combined outcomes. 
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In conclusion, CRF is strongly and independently associated with reduced risk of respiratory diseases 
in a graded dose-response fashion in middle-aged Caucasian men. The prognostic value of CRF for long-
term risk of respiratory diseases warrants evaluation. 
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Figure legend 
 
Figure. Hazard ratios for respiratory diseases, by quartiles of baseline levels of cardiorespiratory fitness 
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A, adjusted for age; B, adjusted for age, smoking status, history of diabetes, prevalent coronary heart 
disease, years of education, total cholesterol, and alcohol consumption  
CRF, cardiorespiratory fitness 
 
 
  
12 
 
Table. Association of cardiorespiratory fitness and risk of respiratory diseases 
CRF 
(ml/kg/min) 
Events/ 
Total 
Model 1  Model 2  Model 3  
  HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value 
Baseline CRF 
Per 1 SD increase 382 / 1,974 0.66 (0.59 to 0.74) < 0.001 0.75 (0.66 to 0.85) < 0.001 0.81 (0.71 to 0.92) 0.001 
Q1 (6.36-25.48) 122 / 494 ref  ref  ref  
Q2 (25.49-30.41) 109 / 493 0.77 (0.59 to 0.99) 0.045 0.90 (0.69 to 1.18) 0.439 0.95 (0.73 to 1.24) 0.713 
Q3 (30.41-35.55) 91 / 494 0.60 (0.46 to 0.80) < 0.001 0.74 (0.55 to 0.98) 0.037 0.85 (0.63 to 1.14) 0.273 
Q4 (35.56-65.40) 60 / 493 0.40 (0.29 to 0.55) < 0.001 0.53 (0.38 to 0.74) < 0.001 0.63 (0.45 to 0.88) 0.008 
Usual CRF* 
Per 1 SD increase 382 / 1,974 0.48 (0.39 to 0.59) < 0.001 0.60 (0.49 to 0.75) < 0.001 0.69 (0.55 to 0.86) 0.001 
Q1 (6.36-25.48) 122 / 494 ref  ref  ref  
Q2 (25.49-30.41) 109 / 493 0.63 (0.40 to 0.99) 0.045 0.83 (0.52 to 1.33) 0.439 0.92 (0.57 to 1.47) 0.713 
Q3 (30.41-35.55) 91 / 494 0.41 (0.25 to 0.67) < 0.001 0.58 (0.35 to 0.97) 0.037 0.75 (0.45 to 1.26) 0.273 
Q4 (35.56-65.40) 60 / 493 0.20 (0.11 to 0.35) < 0.001 0.33 (0.18 to 0.60) < 0.001 0.44 (0.24 to 0.81) 0.008 
 
CI, confidence interval; CRF, cardiorespiratory fitness; HR, hazard ratio; ref, reference; Q, quartile; SD, standard deviation;  
*, indicates correction for within-person variability in values of CRF, that is, the extent to which an individual’s CRF 
measurements vary around a long-term average value (“usual CRF values”) 
Model 1: Adjusted for age  
Model 2: Model 1 plus smoking status, history of diabetes, prevalent coronary heart disease, years of education, total cholesterol, 
and alcohol consumption 
Model 3: Model 2 plus total energy intake, socioeconomic status, physical activity, and C-reactive protein 
 
 
 
 
 
